More effects of extracorporeal magnetic innervation and terazosin therapy than terazosin therapy alone for non-inflammatory chronic pelvic pain syndrome: a pilot study
- PMID: 16683008
- DOI: 10.1038/sj.pcan.4500881
More effects of extracorporeal magnetic innervation and terazosin therapy than terazosin therapy alone for non-inflammatory chronic pelvic pain syndrome: a pilot study
Abstract
The objective of this study was to evaluate whether extracorporeal magnetic innervation (ExMI) combined with alpha-blocker therapy is more effective than alpha-blocker monotherapy for patients with non-inflammatory chronic prostatitis (CP)/chronic pelvic pain syndrome (CPPS), category IIIB. Patients were randomized to either terazosin monotherapy (group 1, n=21) or terazosin combined with ExMI therapy (group 2, n=19). Patients in group 2 had 12 treatment sessions of ExMI twice a week during 6 weeks. None of the patients experienced any side effects from treatment. The changes in each domain of the National Institutes of Health (NIH)-Chronic Prostatitis Symptom Index (CPSI) measured on week 6 were not significantly different between the groups. However, the difference (median, 25-75th percentiles) between the two groups in total NIH-CPSI scores was -4 (-11.5, -2) for group 1 and -12 (-17.3, -2.3) for group 2, respectively (P=0.047). At 6 weeks, 47.6% (10 of 21) of group 1 had a >25% decrease in total NIH-CPSI compared with 78.9% (15 of 19) of group 2 (P=0.041). Also, more patients in group 2 (78.9%) were rated as responders with a 6-point decrease in NIH-CPSI compared with group 1 (47.6%) (P=0.041). The early results suggest that ExMI combined with alpha-blocker therapy has better effect than alpha-blocker monotherapy for the treatment of CP/CPPS.
Similar articles
-
Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo controlled trial.J Urol. 2003 Feb;169(2):592-6. doi: 10.1097/01.ju.0000042927.45683.6c. J Urol. 2003. PMID: 12544314 Clinical Trial.
-
[Retrospective analysis of the combined therapy of terazosin with chlormezanone for chronic prostatitis/chronic pelvic pain syndrome].Zhonghua Nan Ke Xue. 2009 Aug;15(8):717-20. Zhonghua Nan Ke Xue. 2009. PMID: 19852273 Clinical Trial. Chinese.
-
Initial, long-term, and durable responses to terazosin, placebo, or other therapies for chronic prostatitis/chronic pelvic pain syndrome.Urology. 2004 Nov;64(5):881-6. doi: 10.1016/j.urology.2004.06.041. Urology. 2004. PMID: 15533470 Clinical Trial.
-
Identification, pharmacologic considerations, and management of prostatitis.Am J Geriatr Pharmacother. 2011 Feb;9(1):37-48. doi: 10.1016/j.amjopharm.2011.02.005. Am J Geriatr Pharmacother. 2011. PMID: 21459307 Review.
-
Role of alpha1-blockers in chronic prostatitis syndromes.BJU Int. 2008 Mar;101 Suppl 3:11-6. doi: 10.1111/j.1464-410X.2008.07496.x. BJU Int. 2008. PMID: 18307680 Review.
Cited by
-
Efficacy of Magnetic Therapy in Pain Reduction in Patients with Chronic Pelvic Pain: A Systematic Review.Int J Environ Res Public Health. 2022 May 10;19(10):5824. doi: 10.3390/ijerph19105824. Int J Environ Res Public Health. 2022. PMID: 35627359 Free PMC article. Review.
-
Non-pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome.Cochrane Database Syst Rev. 2018 May 12;5(5):CD012551. doi: 10.1002/14651858.CD012551.pub3. Cochrane Database Syst Rev. 2018. PMID: 29757454 Free PMC article. Review.
-
Neuromodulation for Chronic Pelvic Pain.Curr Urol Rep. 2018 Mar 26;19(5):32. doi: 10.1007/s11934-018-0783-2. Curr Urol Rep. 2018. PMID: 29582185 Review.
-
Non-pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome.Cochrane Database Syst Rev. 2018 Jan 26;1(1):CD012551. doi: 10.1002/14651858.CD012551.pub2. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2018 May 12;5:CD012551. doi: 10.1002/14651858.CD012551.pub3. PMID: 29372565 Free PMC article. Updated. Review.
-
Therapeutic intervention for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): a systematic review and meta-analysis.PLoS One. 2012;7(8):e41941. doi: 10.1371/journal.pone.0041941. Epub 2012 Aug 1. PLoS One. 2012. PMID: 22870266 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous